🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Research on Early Prediction Model of Ischemic Cerebrovascular Disease Based on Artificial Intelligence Technology.

Recruitingn/aAges any - anyAllShanghai Jiao Tong University School of Medicine
NCT06978348 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Establish an artificial intelligence clinical decision support system for patients with carotid/vertebral artery cerebrovascular stenosis, early identification of patients who may have cerebral infarction. With the support of this project, it is expected that a secondary prevention clinical decision support system for chronic stroke will be established, which is likely to become an important auxiliary tool for the management of cerebrovascular diseases in the future.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Patients undergoing vascular (carotid/vertebral artery) B-ultrasound Exclusion Criteria: Patients with missing clinical data such as medical history, cerebrovascular ultrasound results and biochemical data
💊

What it tests

  • Not listed
📍

Where

1 site
Model
Shanghai, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy